Compagnie Financière Richemont SA (CFR)
Johannesburg Stock Exchange · South Africa · prices in ZAC · close of 27 Oct 2026
Key indicators
| Last close | ZAC 327,800.00 |
|---|---|
| 52-week range | 278,525.00 – 403,750.00 |
| Return, 1 month / 3 months | −2.9% / −15.9% |
| Return, 1 year / 3 years | −4.4% / +60.9% |
| Trend | Below its 200-day average |
| RSI (14) | 37 |
| Volatility (1 year) | 28.4% |
| Worst drawdown (1 year) | -23.7% |
| Average daily value traded | 42,263.26M ZAC |
| Dividend yield | 2.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Compagnie Financière Richemont SA is a Swiss luxury goods group based in Geneva. It owns a family of luxury houses that design, make and sell jewellery, watches and writing instruments, along with leather goods and fashion accessories. Its brands include Cartier, Van Cleef and Arpels, Montblanc and several watchmakers. The group serves affluent customers around the world through its own boutiques, specialist retailers and online channels, and it also holds interests in other luxury and fashion businesses.
The shares are listed on the Johannesburg Stock Exchange in South Africa under the code CFR, and the price on this page is in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Compagnie Financière Richemont SA (CFR) trades on the Johannesburg Stock Exchange in South Africa. It last closed at ZAC 327,800.00 on 27 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 101 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 4.4% and over the last three months it fell 15.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.8% | ||
| From 52-week high | -18.3% | ||
| Momentum | 37 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -15.9% | ||
| 6-month return | 5.6% | ||
| 12-month return, skipping the last month | -1.5% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 28.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.7% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 42,263.26M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | 37 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.0% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −6.4% |
|---|---|
| 1 month | −2.9% |
| 3 months | −15.9% |
| 6 months | +5.6% |
| 1 year | −4.4% |
| 3 years | +60.9% |
| 5 years | +109.8% |
Signals
| 50-day / 200-day average | 349,229.84 / 337,399.26 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 9,142.27 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Sep 2026 | ZAC 6,541.0950 |
| 17 Sep 2025 | ZAC 6,619.7495 |
| 19 Sep 2024 | ZAC 5,664.5462 |
| 20 Sep 2023 | ZAC 2,096.3055 |
| 21 Sep 2022 | ZAC 1,838.3762 |
| 21 Sep 2021 | ZAC 3,223.9800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.